Finsbury Emerging Biotechnology Tst
20 July 2006
FINSBURY EMERGING BIOTECHNOLOGY TRUST PLC
Results of the AGM
The Company is pleased to announce that at the Annual General Meeting held on 19
July 2006 all resolutions put to the meeting were duly passed.
Resolutions
1. To receive and consider the audited accounts and the Report of the Directors
for the year ended 31 March 2006.
2. To re-elect Mr Paul Gaunt as a Director of the Company.
3. To re-elect Dr John Gordon as a Director of the Company.
4. To re-elect Mr John Sclater as a Director of the Company.
5. To re-elect Mr Anthony Townsend as a Director of the Company.
6. To re-elect Mr Peter Keen as a Director of the Company.
7. To elect Mr Sven Borho as a Director of the Company.
8. To re-appoint RSM Robson Rhodes LLP as auditors and to authorise the
Directors to determine their remuneration.
9. To approve the Directors' Remuneration Report.
10. To adopt the new articles of association of the Company.
11. To authorise the Directors to allot securities in the Company.
12. To disapply the rights of pre-emption in relation to the allotment of
securities contained in section 89 of the Companies Act 1985.
13. To authorise the Company to make market purchases of Ordinary shares in the
Company.
- ENDS-
For further information please contact:
Mark Pope Close Finsbury Asset Management Limited 020 7426 6294
Jo Stonier Quill Communications 020 7758 2230
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.